Meiji Holdings: Notice concerning Approval for Partial Amendment to Manufacturing and Marketing Approval of Kostaive, Self-Amplifying mRNA Vaccine against COVID-19

JPX · Sep 13 14:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.